Agilent Technologies, Inc. (NYSE:A) Short Interest Down 18.9% in May

Agilent Technologies, Inc. (NYSE:AGet Rating) was the target of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 2,880,000 shares, a decline of 18.9% from the May 15th total of 3,550,000 shares. Based on an average daily volume of 1,970,000 shares, the short-interest ratio is currently 1.5 days. Approximately 1.0% of the company’s stock are sold short.

In other Agilent Technologies news, VP Jacob Thaysen sold 5,879 shares of the firm’s stock in a transaction that occurred on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the sale, the vice president now owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Norges Bank acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $455,752,000. Wellington Management Group LLP lifted its stake in shares of Agilent Technologies by 38.8% during the third quarter. Wellington Management Group LLP now owns 8,057,215 shares of the medical research company’s stock worth $1,269,255,000 after purchasing an additional 2,250,500 shares in the last quarter. BlackRock Inc. lifted its stake in shares of Agilent Technologies by 6.8% during the fourth quarter. BlackRock Inc. now owns 29,352,219 shares of the medical research company’s stock worth $4,686,082,000 after purchasing an additional 1,879,602 shares in the last quarter. Two Sigma Advisers LP acquired a new stake in Agilent Technologies during the 3rd quarter valued at $228,450,000. Finally, Goldman Sachs Group Inc. grew its holdings in Agilent Technologies by 67.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,336,607 shares of the medical research company’s stock valued at $309,203,000 after purchasing an additional 942,651 shares in the last quarter.

A has been the subject of several recent research reports. Evercore ISI decreased their price target on Agilent Technologies from $170.00 to $155.00 and set an “outperform” rating for the company in a report on Wednesday, February 23rd. The Goldman Sachs Group reiterated a “buy” rating and set a $170.00 target price on shares of Agilent Technologies in a research report on Thursday, May 26th. Robert W. Baird boosted their target price on Agilent Technologies from $155.00 to $161.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 25th. Stifel Nicolaus dropped their target price on Agilent Technologies from $169.00 to $145.00 and set a “hold” rating on the stock in a research report on Wednesday, February 23rd. Finally, KeyCorp dropped their target price on Agilent Technologies from $195.00 to $155.00 and set an “overweight” rating on the stock in a research report on Thursday, June 2nd. Three analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $159.91.

Agilent Technologies stock traded down $2.25 during trading on Friday, hitting $112.71. The company’s stock had a trading volume of 2,681,452 shares, compared to its average volume of 2,049,432. The stock has a market capitalization of $33.67 billion, a price-to-earnings ratio of 27.59, a P/E/G ratio of 2.38 and a beta of 1.05. The stock’s fifty day moving average is $123.09 and its 200 day moving average is $135.32. Agilent Technologies has a 1-year low of $112.64 and a 1-year high of $179.57. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 2.01.

Agilent Technologies (NYSE:AGet Rating) last released its earnings results on Tuesday, May 24th. The medical research company reported $1.13 EPS for the quarter, beating the consensus estimate of $1.12 by $0.01. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.62 billion. Agilent Technologies had a return on equity of 27.42% and a net margin of 19.35%. The business’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.97 earnings per share. On average, research analysts anticipate that Agilent Technologies will post 4.9 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 27th. Investors of record on Tuesday, July 5th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Friday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.24%.

About Agilent Technologies (Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Recommended Stories

Want More Great Investing Ideas?

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.